Pharmacolog
Edit

Pharmacolog

http://www.pharmacolog.com/
Last activity: 17.05.2024
Active
Categories: AssuranceDrugHardwareMedtechOptimizeProduct
Medication efficacy & safety. Pharmacolog provide solutions & products to optimize intravenous medication and prevent medication errors.
Followers
291
Website visits
8.4K /mo.
Mentions
141
Location: Sweden, Uppsala
Total raised: $223.31K

Funding Rounds 1

DateSeriesAmountInvestors
27.02.2024-$223.31K-

Mentions in press and media 141

DateTitleDescription
17.05.2024Perpetua Medical publishes interim report January - March 2024Perpetua Medical publishes interim report January - March 2024 Fri, May 17, 2024 08:30 CET Report this content Important milestones pave the way for a serial acquiring business. Perpetua Medical AB (publ) announces today that the interim re...
17.05.2024Interim report January 1 – March 31, 2024Interim report January 1 – March 31, 2024 Fri, May 17, 2024 07:45 CET Report this content FIRST QUARTER (JANUARY – MARCH 2024) Oder intake SEK 238.5 M (206.6) Net sales SEK 257.2 M (230.2) Operating profit SEK 45.8 M (23.7) Profit after tax...
15.05.2024NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL)NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL) Wed, May 15, 2024 09:30 CET Report this content The shareholders of Perpetua Medical AB (publ), reg. no. 556723-6418 (the "Company"), are hereby noticed to attend the ...
24.04.2024Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFOPerpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO Wed, Apr 24, 2024 08:30 CET Report this content Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) has appointed Camilla Lönn as the company’s new CFO...
23.04.2024Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company namePerpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name Tue, Apr 23, 2024 08:30 CET Report this content Perpetua Medical AB (formerly Pharmacolog i Uppsala ...
17.04.2024Nolsterby Invest AB has increased its holding further in PharmacologNolsterby Invest AB has increased its holding further in Pharmacolog Wed, Apr 17, 2024 08:30 CET Report this content Nolsterby Invest AB, controlled by Board members Erik Hedlund and Anders Hedlund, has bought shares on April 15 correspondi...
16.04.2024Pharmacolog publishes annual report for 2023Pharmacolog publishes annual report for 2023 Tue, Apr 16, 2024 15:07 CET Report this content Pharmacolog i Uppsala AB (publ) announces today that the annual report for the financial year 2023 has been published. The annual report is attache...
16.04.2024ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024 Tue, Apr 16, 2024 16:42 CET Report this content Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Co...
08.04.2024Nolsterby Invest AB has increased its holding in PharmacologNolsterby Invest AB has increased its holding in Pharmacolog Mon, Apr 08, 2024 08:30 CET Report this content Nolsterby Invest AB, controlled by Board members Erik Hedlund and Anders Hedlund, has during the period April 2-April 5 bought shar...
04.04.2024Pharmacolog announces the appointment of Anders Hedlund as interim CEOPharmacolog announces the appointment of Anders Hedlund as interim CEO Thu, Apr 04, 2024 08:30 CET Report this content The Board has decided to appoint Anders Hedlund as interim CEO of the company. He replaces thereby Lars Gusch who will st...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In